Viva Pharm: Funding, Investors & Team (Sep 2026)
Viva Pharm is a pharmaceutical company that specializes in providing medications for patients, focusing on the processes of development, clinical research, registration, production, storage, and distribution.
Viva Pharm has raised $2.2M across 1 funding round on record, the most recent an undisclosed round of $2.2M announced in Jun 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Viva Pharm Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Viva Pharm Funding Rounds
Viva Pharm Founders and Leadership Team
No contact details are on record for this team yet.
Viva Pharm Funding Compared to Other Biotechnology Startups
Viva Pharm's latest round of $2.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Viva Pharm in Biotechnology and Almaty
Companies Similar to Viva Pharm
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Viva Pharm Funding FAQs
What does Viva Pharm do?
Viva Pharm is a pharmaceutical company that specializes in providing medications for patients, focusing on the processes of development, clinical research, registration, production, storage, and distribution.
How much funding has Viva Pharm raised?
Viva Pharm has raised $2.2M across 1 round on record. The most recent is an undisclosed round of $2.2M announced in Jun 2023.
When did Viva Pharm last raise funding?
Viva Pharm's most recent funding round on record is an undisclosed round of $2.2M, announced in Jun 2023.
Who founded Viva Pharm?
FundedIQ lists Jason Ko (Founder) at Viva Pharm.
Where is Viva Pharm headquartered?
Viva Pharm is based in Almaty, Kazakhstan.
How many employees does Viva Pharm have?
Viva Pharm is in the 101-250 employee band.
How does Viva Pharm's funding compare to other Biotechnology startups?
Viva Pharm's latest round of $2.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Viva Pharm Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Viva Pharm is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.